TY - JOUR
T1 - Smoking cessation treatment among office-based buprenorphine treatment patients
AU - Nahvi, Shadi
AU - Blackstock, Oni J.
AU - Sohler, Nancy L.
AU - Thompson, Devin
AU - Cunningham, Chinazo O.
N1 - Funding Information:
This work was supported by HRSA Special Projects of National Significance (grant 6H97HA00247), National Institute on Drug Abuse of the National Institutes of Health (K23DA025736, R25DA023021, R01DA032110, and R34DA031066), and the Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center (NIH AI-51519).
PY - 2014/8
Y1 - 2014/8
N2 - Opioid-dependent patients smoke at high rates, and office-based buprenorphine treatment provides an opportunity to offer cessation treatment. We examined tobacco use and smoking cessation treatment patterns among office-based buprenorphine treatment patients. We reviewed records of 319 patients treated with buprenorphine from 2005 to 2010. We examined smoking status, cessation medication prescriptions, and factors associated with receipt of cessation prescriptions. Mean age was 43.9. years; most were men (74.2%) and Hispanic (70.9%). At buprenorphine initiation, 21.9% had no documentation of smoking status, while 67.4% were current, 10% former, and 0.9% never smokers. Of current smokers, 16.8% received smoking cessation prescriptions. Patients retained (vs. not retained) in buprenorphine treatment were more likely to receive smoking cessation medications (26.3% vs. 11.2%, p. <. 0.005). We observed a high tobacco use prevalence among buprenorphine patients, and limited provision of cessation treatment. This is a missed opportunity to impact the high tobacco use burden in opioid-dependent persons.
AB - Opioid-dependent patients smoke at high rates, and office-based buprenorphine treatment provides an opportunity to offer cessation treatment. We examined tobacco use and smoking cessation treatment patterns among office-based buprenorphine treatment patients. We reviewed records of 319 patients treated with buprenorphine from 2005 to 2010. We examined smoking status, cessation medication prescriptions, and factors associated with receipt of cessation prescriptions. Mean age was 43.9. years; most were men (74.2%) and Hispanic (70.9%). At buprenorphine initiation, 21.9% had no documentation of smoking status, while 67.4% were current, 10% former, and 0.9% never smokers. Of current smokers, 16.8% received smoking cessation prescriptions. Patients retained (vs. not retained) in buprenorphine treatment were more likely to receive smoking cessation medications (26.3% vs. 11.2%, p. <. 0.005). We observed a high tobacco use prevalence among buprenorphine patients, and limited provision of cessation treatment. This is a missed opportunity to impact the high tobacco use burden in opioid-dependent persons.
KW - Buprenorphine
KW - Office-based treatment
KW - Opioid
KW - Smoking cessation
KW - Tobacco smoking
UR - http://www.scopus.com/inward/record.url?scp=84903151258&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84903151258&partnerID=8YFLogxK
U2 - 10.1016/j.jsat.2014.04.001
DO - 10.1016/j.jsat.2014.04.001
M3 - Article
C2 - 24912863
AN - SCOPUS:84903151258
SN - 0740-5472
VL - 47
SP - 175
EP - 179
JO - Journal of Substance Abuse Treatment
JF - Journal of Substance Abuse Treatment
IS - 2
ER -
